NTRB News and Press, Nutriband Inc. From 09/25/25

NEW YORK, NY / ACCESS Newswire / September 25, 2025 / The MicroCap Rodeo Conference is live today, featuring presentations from the CEOs and executive management teams of 11 dynamic microcap companies across a wide range of industries. Investors will have the opportunity to hear directly from...

ORLANDO, Fla., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (The Company) (Nasdaq:NTRB) (Nasdaq: NTRBW), announces it will participate in the MicroCap Rodeo Conference, to be held Thursday, June 25, 2025, in New York City. For example: Company Chairman, Serguei Melnik, will be attending ...

2025-09-19 13:56:27 ET Nutriband (NASDAQ: NTRB) is a transdermal pharmaceutical developer that has secured crucial FDA engagement for its lead abuse-deterrent technology. “Nutriband’s FDA Type C Meeting approval for AVERSA(TM) Fentanyl signals agency recognition of the pro...

2025-09-10 12:45:27 ET Nutriband (NASDAQ: NTRB) reported financial results for the six months ended July 31, 2025, highlighted by revenue of $1.29 million, up 50.87% year over year, and cash reserves of $6.9 million. The company said the strong balance sheet supports the advancement of ...

2025-09-10 09:34:10 ET More on Nutriband Nutriband announces exercise of warrants at $6.43 for gross proceeds of $5.31M Seeking Alpha’s Quant Rating on Nutriband Historical earnings data for Nutriband Financial information for Nutriband Read ...

ORLANDO, Fla., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) reported its financial results for the six months ended July 31, 2025. The company reported a strong cash position at quarter end, reinforcing its ability to advance the development of its lead product, ...

2025-09-09 15:45:23 ET Nutriband (NASDAQ: NTRB) was featured in a recent publication that discussed the company’s milestones, innovative platform, and lead product, AVERSA(TM) Fentanyl. NTRB’s technology “incorporates aversive agents into fentanyl patches to prevent...

Maple Leaf Green World (MGWFF) is expected to report for quarter end 2025-06-30 Nano Dimension Ltd. (NNDM) is expected to report for Q2 2025 Stratex Oil & Gas Holdings Inc (STTX) is expected to report for Q2 2025 Cantaloupe Inc. (CTLP) is expected to report $0.11 for Q4 2025 F...

2025-09-04 09:25:00 ET Nutriband (NASDAQ: NTRB) , a company developing abuse deterrent pharmaceutical products, announced the exercise of warrants at a strike price of $6.43, generating $5,306,000 in proceeds. The funds will support the remaining clinical development of AVERSA Fentanyl ...

2025-09-03 16:11:25 ET More on Nutriband Nutriband issued U.S. patent for transdermal abuse deterrent technology Seeking Alpha’s Quant Rating on Nutriband Historical earnings data for Nutriband Financial information for Nutriband Read the ful...